CLPT

ClearPoint Neuro, Inc. Common Stock

13.72

USD

+0.24

+1.78%

Sep 11, 15:59 UTC -4

Closed

After-Market

13.70

-0.02

-0.15%

ClearPoint Neuro, Inc. Common Stock Profile

About

ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California.

Info & Links

CEO

Joseph M. Burnett

Headquarters

120 S. SIERRA AVE., SUITE 100
SOLANA BEACH, CA 92075, UNITED STATES

Auditor

Cherry Bekaert LLP

Share holders

184

Employees

172

ClearPoint Neuro, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

417.88M

Enterprise Value

438.75M

Enterprise Value/EBITDA(ttm)

-16.18

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

9.73

Price to Book(mrq)

38.16

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

62.59%

Operating Margin(ttm)

-81.76%

Profit Margin(ttm)

-81.06%

Return on Equity(ttm)

-188.09%

Return on Invested Capital(ttm)

-55.70%

Return on Assets(ttm)

-40.88%

Income Statement

Revenue(ttm)

42.28M

Revenue Per Share(ttm)

1.39

Gross Profit(ttm)

26.47M

EBITDA(ttm)³

-27.12M

Net Income Available to Common(ttm)

-34.57M

Diluted EPS(ttm)

-1.18

Share Statistics

Beta (5Y Monthly)

1.26

52-Week Change

30.29%

S&P 500 52-Week Change

18.73%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

30.50M

Dividend Yield

0.00%

Float⁴

28.39M

% Held by Insiders

6.94%

% Held by Institutions

30.08%

Balance Sheet

Total Cash(mrq)

29.36M

Total Cash Per Share(mrq)

0.96

Total Debt(mrq)

50.23M

Total Debt/Equity(mrq)

466.15%

Current Ratio(mrq)

4.74%

Quick Ratio(mrq)

3.89%

Book Value Per Share(mrq)

0.35

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.50

Free Cash Flow(ytd)

-15.84M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.